Skip to main content

Table 3 The relationship between ferroportin expression and hepatocellular carcinoma (HCC) clinical characteristics (n (%))

From: RETRACTED ARTICLE: Ferroportin in the progression and prognosis of hepatocellular carcinoma

Characteristic Expression level of ferroportin P
  0 1 to 3 4 to 5 6 to 7  
Intrahepatic metastasis      0.008*
  + 10 (83.3) 2(16.7) 0 (0) 0 (0)
  - 33 (68.8) 7(14.6) 6(12.5) 2(4.2)
Portal vein invasion      0.007*
  + 10 (90.9) 1 (9.1) 0 (0) 0 (0)
  - 33 (67.3) 8 (16.3) 6 (12.2) 2 (4.1)
Edmondson-Steiner grading      0.02*
  I to II 22 (64.7) 5 (14.7) 5 (14.7) 2 (5.9)
  III to IV 21(80.8) 4 (15.4) 1 (3.8) 0 (0)
TNM staging      0.01*
  I to II 22 (64.7) 5 (14.7) 5 (14.7) 2 (5.9)
  III to IV 21 (80.8) 4 (15.4) 1 (3.8) 0(0)
AFP (ng/mL)      0.18
≤400 7 (14.3) 24(49) 15 (30.6) 3 (6.1)
>400 1 (9.1) 5(45.5) 4(36.4) 1 (9.1)  
  1. *P < 0.05. AFP, alpha-fetoprotein; TNM, tumor node metastasis.